Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1993-08-20
1995-03-14
Henley, III, Raymond G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
A61K 3159
Patent
active
053977769
ABSTRACT:
A birth control method for a female mammal which comprises administering to the mammal an amount of a vitamin D compound sufficient to block binding of progesterone to the progesterone receptor in said mammal.
REFERENCES:
Kumar et al. Vitamin D and Calcium Hormones in Pregnancy. N. Eng. J. Med. 1980; 302(20); 1143-4.
"Synthesis and Biological Activity of 3.beta.-Hydroxy-9,10-Secopregna-5,7,10[19]-Triene-20-One: A Side Chain Analogue of Vitamin D.sub.3 ", Murari et al, Biochem, vol. 17, 1982, pp. 615-619.
Darwish Hisham M.
DeLuca Hector F.
Perlman Kato L.
Henley, III Raymond G.
Spivack Phyllis G.
Wisconsin Alumni Research Foundation
LandOfFree
Vitamin D compounds with anti-progesterone activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin D compounds with anti-progesterone activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin D compounds with anti-progesterone activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-713849